Invesco FTSE RAFI US 1000 ETF

37.56

-0.5200-1.37%

Pre-market: 37.560.00000.00%08:03 EDT

Volume:440.29K

Turnover:16.58M

Market Cap:7.09B

PE:23.47

High:38.15

Open:37.95

Low:37.27

Close:38.08

Loading ...

Overview Company News Filings

Concept

ETF & Stock Investment-2.05%

Fractional Shares-2.05%

Capital Flow

Inflow:

Outflow:

News

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PRF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRF\",,,,,undefined,":{"symbol":"PRF","market":"US","secType":"STK","nameCN":"Invesco FTSE RAFI US 1000 ETF","latestPrice":37.56,"timestamp":1744833600000,"preClose":38.08,"halted":0,"volume":440289,"hourTrading":{"tag":"盘前","latestPrice":37.56,"preClose":37.56,"latestTime":"08:03 EDT","volume":174,"amount":6535.4400000000005,"timestamp":1744891417268},"delay":0,"floatShares":188730000,"shares":188730000,"eps":1.60003,"marketStatus":"Pre-Mkt","change":-0.52,"latestTime":"04-17 08:04:01 EDT","open":37.95,"high":38.1473,"low":37.27,"amount":16582749.502134,"amplitude":0.023038,"askPrice":41.24,"askSize":100,"bidPrice":31.45,"bidSize":100,"shortable":3,"etf":1,"ttmEps":1.60003,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1744896600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":37.56,"sharesOutstanding":188730000,"nav":38.07699,"aum":7186270322.7,"bidAskSpread":0.000713,"preHourTrading":{"tag":"盘前","latestPrice":37.56,"preClose":37.56,"latestTime":"08:03 EDT","volume":174,"amount":6535.4400000000005,"timestamp":1744891417268},"postHourTrading":{"tag":"盘后","latestPrice":37.56,"preClose":37.56,"latestTime":"16:14 EDT","volume":8,"amount":300.75,"timestamp":1744834496175},"volumeRatio":0.39003342696014215,"impliedVol":0.0685,"impliedVolPercentile":0.428},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRF\",,,,,undefined,":{"symbol":"PRF","floatShares":188730000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.39003342696014215,"shares":188730000,"dividePrice":0.74639,"high":38.1473,"amplitude":0.023038,"preClose":38.08,"low":37.27,"week52Low":34.98,"pbRate":"--","week52High":43.015,"institutionHeld":0,"latestPrice":37.56,"eps":1.60003,"divideRate":0.019872,"volume":440289,"delay":0,"ttmEps":1.60003,"open":37.95,"prevYearClose":40.34,"prevWeekClose":37.73,"prevMonthClose":40.41,"prevQuarterClose":40.41,"fiveDayClose":38.44,"twentyDayClose":40.72,"sixtyDayClose":42},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PRF\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"ETF & Stock Investment","bkCode":"BK4585","id":"package_us_concept_etf&gpdt","changeRate":-0.020548},{"market":"US","name":"Fractional Shares","bkCode":"BK4588","id":"package_us_concept_sg","changeRate":-0.020548}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PRF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2494381267","title":"BRIEF-PainReform Provides Further Update On Phase 3 Clinical Trial Of PRF-110","url":"https://stock-news.laohu8.com/highlight/detail?id=2494381267","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494381267?lang=en_us&edition=fundamental","pubTime":"2024-12-27 23:24","pubTimestamp":1735313098,"startTime":"0","endTime":"0","summary":"Dec 27  - PainReform Ltd   :   * PAINREFORM PROVIDES FURTHER UPDATE ON PHASE 3 CLINICAL TRIAL OF PRF-110   * PAINREFORM LTD: DATA FROM FINAL 24-HOUR PERIOD COULD NOT BE CLARIFIED TO SATISFY STUDY'S PRIMARY ENDPOINT 72 HOURS REQUIREMENT   * PAINREFORM LTD: DATA FROM FINAL 24-HOUR PERIOD DID NOT MEET PRIMARY ENDPOINT OF STUDY   * PAINREFORM LTD - INITIATES RESEARCH AND DEVELOPMENT ACTIVITIES TO REFINE PHARMACO-KINETICS AND PHARMACO-DYNAMICS OF PRF-110Source text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4007","PRFX","BK4585","PRF"],"gpt_icon":1},{"id":"2494385472","title":"PainReform Faces Setback in Phase 3 Trial for PRF-110","url":"https://stock-news.laohu8.com/highlight/detail?id=2494385472","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494385472?lang=en_us&edition=fundamental","pubTime":"2024-12-27 22:17","pubTimestamp":1735309031,"startTime":"0","endTime":"0","summary":"PainReform ( ($PRFX) ) has provided an update. PainReform announced that its Phase 3 clinical trial for PRF-110 did not meet its primary endpoint o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/painreform-faces-setback-in-phase-3-trial-for-prf-110?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/painreform-faces-setback-in-phase-3-trial-for-prf-110?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","PRF","PRFX","BK4588"],"gpt_icon":0},{"id":"2494002038","title":"PainReform Phase 3 trial on PRF-110 did not meet primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2494002038","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494002038?lang=en_us&edition=fundamental","pubTime":"2024-12-27 21:35","pubTimestamp":1735306536,"startTime":"0","endTime":"0","summary":"PainReform (PRFX) announced an update regarding its Phase 3 clinical trial evaluating PRF-110 in post-surgical pain management of patients undergoi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/painreform-phase-3-trial-on-prf-110-did-not-meet-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/painreform-phase-3-trial-on-prf-110-did-not-meet-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","PRF","PRFX","BK4588","BK4585"],"gpt_icon":0},{"id":"2494248800","title":"PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110","url":"https://stock-news.laohu8.com/highlight/detail?id=2494248800","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494248800?lang=en_us&edition=fundamental","pubTime":"2024-12-27 21:30","pubTimestamp":1735306200,"startTime":"0","endTime":"0","summary":"TEL AVIV, Israel, Dec.  27, 2024  (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (\"PainReform\" or the \"Company\"), a clinical-stage specialty pharmaceutical company focused on the reformulation of ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/27/3002246/0/en/PainReform-Provides-Further-Update-on-Phase-3-Clinical-Trial-of-PRF-110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRFX","PRF","BK4588","BK4007","BK4585"],"gpt_icon":1}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRF\",params:#limit:5,,,undefined,":[{"date":"2025-03-24","symbol":"PRF","amount":0.18939,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"Invesco FTSE RAFI US 1000 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PRF","amount":0.19719,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"Invesco FTSE RAFI US 1000 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-27"},{"date":"2024-09-23","symbol":"PRF","amount":0.18655,"announcedDate":"2024-09-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-23","defaultRemindTime":1727098200000,"name":"Invesco FTSE RAFI US 1000 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-27","payableDate":"2024-09-23","currency":"USD","dateTimestamp":1727064000000,"payDate":"2024-09-27"},{"date":"2024-06-24","symbol":"PRF","amount":0.17326,"announcedDate":"2024-06-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco FTSE RAFI US 1000 ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"date":"2024-03-18","symbol":"PRF","amount":0.16136,"announcedDate":"2024-03-15","type":"dividend","market":"US","newRecordDate":"2024-03-19","defaultRemindTime":1710768600000,"name":"Invesco FTSE RAFI US 1000 ETF","recordDate":"2024-03-22","payableDate":"2024-03-19","currency":"USD","dateTimestamp":1710734400000,"payDate":"2024-03-22"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRF\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-19","recordDate":"2015-06-23","paymentDate":"2015-06-30","value":0.44738,"currency":"USD"},{"executeDate":"2015-09-18","recordDate":"2015-09-22","paymentDate":"2015-09-30","value":0.47975,"currency":"USD"},{"executeDate":"2015-12-18","recordDate":"2015-12-22","paymentDate":"2015-12-31","value":0.73856,"currency":"USD"},{"executeDate":"2016-03-18","recordDate":"2016-03-22","paymentDate":"2016-03-31","value":0.32975,"currency":"USD"},{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-06-30","value":0.43751,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRF\",market:\"US\",delay:false,,,undefined,":{}}}